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NEONATOLOGY
K. de Meer · K. R. Westerterp · R. H. J. Houwen
H. A. A. Brouwers · R. Berger · A. Okken
Total energy expenditure in infants with bronchopulmonary dysplasia
is associated with respiratory status
Received: 17 January 1996 / Accepted: 23 July 1996
Abstract Growth failure is a well-known problem in
infants with bronchopulmonary dysplasia (BPD). We
studied BPD infants’ total daily energy expenditure (Ee),
nutritional balance, and growth in relation to their past
and current clinical status. Applying the doubly labelled
water technique, Ee was measured in nine preterm in-
fants with BPD receiving supplemental oxygen (post-
natal age 61 ± 13 days) and nine matched controls
(36 ± 21 days) during a 6-day period. Energy and pro-
tein balance, past and present respiratory status, and
growth were assessed as well. The results show that Ee
was higher in the BPD infants compared to controls
(73 ± 9 vs 63 ± 8 kcal/kg/day, P < 0.05), but their faecal
energy loss was lower (P < 0.01). Weight gain, energy
intake, energy cost of growth, protein retention, and
physical activity were not different. The respiratory fre-
quency (RR) in the BPD infants was elevated in com-
parison with controls (P < 0.01). Within the BPD
group, RR was positively correlated with energy ex-
penditure (regression equation: Ee [kcal/kg/day] = 26.3
+ 0.71*RR [min)1]; r2 = 0.82, P < 0.001), and was the
single most significant determinant of Ee.
Conclusion Total energy expenditure in BPD infants is
elevated and is strongly associated with their respiratory
status. These findings could be of practical value for the
nutritional management in infants with severe BPD.
Key words Preterm infant · Bronchopulmonary
dysplasia · Energy expenditure · Growth · Corticosteroids
Abbreviations BPD bronchopulmonary dysplasia · Ee
total daily energy expenditure · FiO2 inspiratory fraction
of oxygen · RR respiratory frequency
Introduction
Growth failure is a well-known problem in infants with
bronchopulmonary dysplasia (BPD) [1, 14, 22] but its
determinants have not yet been fully elucidated. Dis-
turbances in energy balance have been implicated with
growth failure in BPD infants. Several controlled studies
have demonstrated increased energy expenditure in in-
fants with BPD [4, 11, 12, 19, 21] and a lower energy
intake has been described in some of these studies. The
application of the method of respiratory gas exchange,
which was used to measure oxygen consumption and
carbon dioxide production in these studies (in order to
calculate energy expenditure), has been criticized [9].
Accurate measurements of oxygen consumption and
carbon dioxide production require that the inspiratory
oxygen fraction (F1O2) and flow of supplemental oxygen
are kept constant, which is very difficult to achieve in
BPD infants receiving supplemental oxygen.
The aim of the present study was to measure energy
expenditure of infants with BPD and controls, applying
the doubly labelled water technique which has the ad-
vantage of measuring total daily energy expenditure (Ee)
over a period of days and is independent of oxygen
supplementation. We also studied the relation between
energy expenditure, weight gain, and clinical parameters,
taking into account aspects of nutrient balance as well as
past and present respiratory status in patients with mild
and severe symptoms of BPD.
Patients and methods
Subjects
Assuming a significance level of 0.05 with a power of 80%, it was
calculated from previous results in premature infants [20] that a
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minimal group size of eight infants in each group was required to
measure an inter-group difference in Ee of 15%. We studied nine
preterm infants with BPD and nine control infants (Table 1). The
infants were matched for birth weight and gestational age. The
control infants had had no or only mild, transient respiratory
distress (supplemental oxygen less than 3 days postpartum), and
showed no signs of respiratory distress at the time of the study.
Infants with BPD were enrolled according to the Bancalari et al. [2]
criteria. These infants had had moderate to severe respiratory
distress after birth that required mechanical ventilation for 12–28
days. Eight BPD infants received exogenous surfactant. Severity of
neonatal respiratory distress was scored according to Palta et al.
[15]. At the time of the study the BPD infants had had their
endotracheal tubes removed. All showed signs of respiratory dis-
tress, and they still received oxygen therapy. All had received
corticosteroid therapy: hydrocortisone therapy was started in the
4th or 5th postnatal week at an initial dose of 5 mg/kg per day, and
subsequently tapered in 4 weeks. In three infants a second cor-
ticosteroid course was given because severe respiratory distress
recurred during tapering. At the time of the study eight BPD in-
fants received hydrocortisone (mean dose 3 mg/kg/day); they were
also treated with diuretics. The infants were maintained in a tem-
perature-controlled neonatology ward (average temperature 29°C),
and nursed in an incubator or in bed (if body weight > 2 kg).
The study was approved by the scientific and medical ethical
committee of our hospital. Consent for the study was obtained in
each case.
Nutrition
All patients were fed through a nasogastric tube with standard
formulas (Nenatal [Nutricia, 80 kcal and 2.1 g protein/100 ml] or
Nutrilon Premium [Nutricia, 67 kcal and 1.5 g protein/100 ml].
Fluid intake was prescribed individually, taking into account the
respiratory and cardiac status of the infant. According to judge-
ment of the attending physician, the formula was fortified with
supplemental formula powder, glucose polymers (Caloreen, Clin-
tec) or soya fat emulsion (Nutricia). Food quotients, calculated
from formula mixtures, were no different between the patient and
control groups. Food intake was kept constant during, and 2 days
in advance of, the study period.
Methods
From days 1 to 6 total daily Ee was measured with the doubly
labeled water technique as previously described [20]. Briefly, iso-
topes (0.25 g H2
18O and 0.13 g 2H2O per kg) were administered
through a nasogastric tube, urine samples were collected daily, and
isotope enrichment was measured by isotope ratio mass spect-
rometry. Water turnover and Ee were calculated from isotope
disappearance [20], assuming a respiratory quotient of 0.89 in both
groups of infants [8].
Heart rate, respiratory frequency (RR), and transcutaneous
oxygen saturation were monitored continuously (Hewlett Packard,
and Nellcor Instruments, USA), and recorded every hour. On day
4, physical activity was monitored during 1 min at 30-min intervals
with the visual observation scale described by Freymond et al. [5].
From days 4 to 6 a balance study was performed. Nutritional in-
take was measured as previously described [18]. Urine was collected
with self-adhesive bags during 24 h, divided into four collection
periods of 6 h. Urine bags were emptied at nursing times, the urine
was transposed with syringes into plastic containers kept at 4°C
until the end of each period, and then frozen at )20°C until anal-
ysis. Urine that leaked from the collection bag was collected in
diapers that were weighed before and after each nursing period;
urinary nitrogen excretion was corrected for these losses. Urine
collection was complete for > 90% of total urine output in all but
one patient. During 72 h, the faeces was collected in the diapers
with fat-free paper which retained the faeces but not the urine.
Faecal specimens were transposed into plastic containers and fro-
zen as described above. Calculations of faecal energy and nitrogen
loss were corrected for faeces retained in the collection paper.
Faecal collections were approximately > 90% complete. Energy
stored was calculated from energy intake minus faecal energy loss
minus Ee (Urinary energy loss is very small and was neglected in
the calculations). Nitrogen intake and nitrogen loss (in 72 h faeces
collections, as well as in 24 h urine collected on day 4) were mea-
sured with a standard technique (modified Micro-Kjeldahl method)
[13]. Protein balance was calculated assuming that 1g of nitrogen
represents 6.25 g of protein.
Growth rates were assessed from anthropometry performed on
days 1 and 6, assuming linear growth. Body weight was measured
with an electronic scale (Seca, Germany) with an accuracy of 5g.
Measurements of skeletal growth (crown-heel length, crown-rump
length, and arm span) were made with the infant in the supine
position, using a measuring device resembling the Harpenden in-
fantometer [6]. Head circumference was measured as described by
Gerver et al. [7].
All measurements were normally distributed, and are reported
as mean ± SD unless otherwise stated. Statistical comparisons were
made with unpaired t tests. Simple and multiple regression analyses
were also conducted. Statistical differences were considered signif-
icant if P < 0.05 (two-tailed).
Results
Infants in both groups had similar Apgar scores, but
differences existed in gender distribution, and postnatal
and post-conceptual age (Tables 1, 2).
Nutritional balance and growth
Table 3 shows the results of the balance studies. Fluid
intake and water turnover were significantly lower in the
BPD infants than in controls. Energy intake in both
Table 1 Neonatal clinical fea-
tures of BPD patients and con-
trols
Mean ± SD.
a None of the BPD infants had
primary heart disease or initial
lung disease other than surfac-
tant deficiency.
b No, or only minimal re-
spiratory distress during the
first three days of life.
BPD infantsa Control infants
Duration of pregnancy [weeks] 29.1 ± 1.4 29.8 ± 1.7
(range 27–31) (range 27–32)
Male/female 9/0 5/4
Birth weight [g] 1106 ± 303 1206 ± 362
Apgar score:
-at 1 min 5.3 ± 2.6 5.1 ± 2.7
-at 5 min 7.3 ± 2.0 8.1 ± 1.1
Neonatal respiratory distress:
-Severity score (Palta et al.) 65 ± 14 –b
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groups was similar but faecal energy loss was signifi-
cantly lower in the BPD infants than in controls
(P < 0.001). Mean Ee was 16% higher in the BPD in-
fants than in the control infants (73 vs 63 kcal/kg/day
[303 vs 262 kJ/kg/day], P = 0.03). All infants had a
positive energy balance during the study. As a result,
energy stored was not significantly different between
both groups. Within the BPD group energy stored was
significantly associated with energy intake (r2 = 0.78,
P < 0.01), but not with Ee (r2 = 0.09, NS).
Both groups of infants had similar values for ant-
hropometric parameters (Table 2), but total body water
was significantly higher in the controls than in the BPD
infants (P < 0.05). Weight gain and energy cost of
growth were very similar in both groups (12.9 ± 5.4
g/kg/day and 3.5 ± 1.4 kcal/g in BPD infants vs
12.6 ± 3.5 g/kg/day and 3.5 ± 1.7 kcal/g in controls
(NS), respectively). As shown in Table 3, growth ve-
locities of head circumference were not significantly
different between both groups, but the mean velocity of
skeletal growth was significantly lower in the BPD in-
fants compared to controls (P = 0.03) . In the BPD
infants, the steroid dose received during the study pe-
riod was not significantly associated with growth ve-
locities.
Clinical status and energy expenditure
Physical activity score and heart rate were similar in
both groups (Table 2), but RR was significantly higher
in the BPD patients compared to the control infants
(65 ± 12 vs 50 ± 6 breaths/min, P = 0.005). Mean Ee in
the four BPD infants who had a RR > 62 breaths/min
(i.e. above the 95th percentile of RR in the controls),
was 79 kcal/kg per day (331 kJ/kg per day), that is 25%
increased compared to control values. Univariate cor-
relation analyses showed significant associations be-
tween RR (P < 0.001), heart rate (P < 0.05), and FiO2
(P < 0.01), and Ee as dependent variable (r2 = 0.82,
0.69, and 0.69, respectively). In multiple regression
analysis, these three factors predicted a high propor-
tion of the variance in Ee within the group of BPD in-
fants (multiple r2 = 0.94, P < 0.01; regression equa-
tion: Ee = )72 )56.6 * FiO2 + 0.64 * heart rate +
0.95 * RR). For RR, the single most significant deter-
minant of Ee (r2 = 0.82, P < 0.001), the regression
equation was: Ee [in kcal/kg/day] = 26.3 + 0.71 * RR [in
breaths/min]). Figure 1 depicts the relationship between
RR and Ee in the BPD infants; in the control infants no
association between RR and Ee was present. In the BPD
group, FiO2 at postnatal day 28 was significantly cor-
Table 2 Features of BPD
patients and controls during the
study period
Mean ± SD
NA Not available. Significant
difference to controls (t test):
*P < 0.01, **P < 0.05.
BPD infants Control infants
Start study protocol:
-postnatal days 61* ± 14 36 ± 21
-post-conceptual weeks 38** ± 2 34 ± 3
FiO2 (range) [l/l] 0.23 ) 0.55 Room air
Oxygen saturation [%] 92 ± 2 NA
Respiration rate [min)1] 65* ± 12 50 ± 6
Heart rate [min)1] 158 ± 8 153 ± 9
Physical activity [Freymond score] 0.66 ± 0.20 0.62 ± 0.05
Body weight [g] 2000 ± 492 1752 ± 454
Total body water [% body weight] 73** ± 6 80 ± 4
Crown heel length [*10)1 m] 43.1 ± 3.7 42.4 ± 3.1
Head circumference [*10)1 m] 31.0 ± 2.4 30.0 ± 2.2
Table 3 Nutritional balance
studies and growth rates
Mean ± SD.
Significant difference with con-
trols (t test): ***P < 0.05,
* P < 0.01, ** P < 0.001.
a Arithmic mean of crown-heel
length, crown-rump length, and
arm span. In a principal com-
ponents analysis, these para-
meters formed one factor
(Eigenvalue 1.47, percentage of
variance: 49%).
b Male and female controls:
60 ± 8 and 66 ± 8 kcal/kg/day,
respectively (t test: NS).
BPD infants Control infants
Water [ml/kg/day]:
-fluid intake 117* ± 6 156 ± 14
-water turnover 132** ± 12 161 ± 20
Energy [kcal/kg/day]:
-intake (Ei) 119 ± 16 117 ± 8
-faecal loss (El) 6* ± 3 14 ± 8
-total energy expenditure (Ee) 73*** ± 9 63b ± 8
-energy stored (Es) 40 ± 13 40 ± 13
Protein [g/kg/day]:
-intake 2.93 ± 0.21 3.05 ± 27
-faecal loss 0.13** ± 0.07 0.38 ± 0.16
-urine loss 0.72 ± 0.41 0.54 ± 0.29
-protein retention 2.08 ± 0.46 2.13 ± 44
Growth rates:
Body weight [g/kg/day] 12.9 ± 5.4 12.6 ± 3.5
Skeletal growtha [mm/m/day] 1.9*** ± 2.7 3.5 ± 2.5
Head circumference [mm/m/day] 1.8 ± 4.2 3.9 ± 3.4
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related with Ee (r2 = 0.84, P < 0.005), but factors in the
patient history (birth weight, days on mechanical ven-
tilation, Palta score), and current anthropometric status,
physical activity score, and steroid dose were not sig-
nificantly associated with Ee.
Outcome
Three BPD infants later died due to pulmonary or car-
diac insufficiency, all within the first 6 months after
birth. In retrospect, respiratory status in these infants
had been more serious during the study period (Fig. 1).
No differences existed in energy and protein retention
and growth during the study period between BPD in-
fants who died compared to the survivors. At a cor-
rected age of 1 year, two out of the six survivors (but
none of the controls) had a supine length below the 3rd
percentile of the Dutch reference population [17].
Discussion
The results of the present study indicate that total daily
energy expenditure in infants with BPD is increased and
that Ee in these patients is strongly associated with
clinical parameters of pulmonary dysfunction (respira-
tory frequency and FiO2).
With respect to the elevated energy expenditure in
BPD infants, the finding that Ee is 16% increased over
control values is in close agreement with previous studies
in BPD infants using respiratory calorimetry which re-
ported an increase of approximately 25% [4, 19, 21].
However, two potential sources of bias in our study
should be considered. Firstly, gender distribution was
uneven in our study. According to the literature, energy
expenditure in preterm and term female infants is higher
than in male infants [3]. In our control group, females
had a 10% higher Ee than males but the difference was
not statistically significant. Secondly, postnatal age in
the BPD infants was almost twice that of controls (61 vs
36 days) and this was also reflected in differences in their
post-conceptual age. Finding an adequate control group
was a problem in this and previous (e.g. [12]) studies of
BPD infants. The Ee of healthy infants of comparable
post-conceptual age as the BPD patients would be ex-
pected to be similar or even lower than in our control
infants [16, 20, 22]. Gender and age bias might have
obscured a real larger difference in Ee between our in-
fants with BPD and the present control group. None-
theless, Ee was significantly elevated in the BPD group
(which included infants with FiO2 requirements ranging
from 0.23–0.55). Differences in postnatal age might also
explain the lower faecal energy and protein loss in the
BPD patients compared to the controls because gut
maturation and increased body fat mass are well-known
correlatives of postnatal growth in preterm infants. The
lower proportion of body water in the BPD patients also
could be related to their maturation, however, lower
fluid intake and use of diuretics in the BPD group may
also be associated with their lower proportion of body
water. It cannot be excluded that the above differences
between the patient and control groups are the result of
other confounding factors such as steroid use. Within
the BPD group no significant correlations existed be-
tween water intake and dose of steroids or diuretics and
Ee and faecal energy and protein loss and proportion of
body water.
With respect to associations with the patients clinical
status, severity of pulmonary disease, as indicated by
current RR and FiO2, was significantly associated with
Ee of the BPD infants in our study. Pulmonary status
was not associated with other components of the energy
balance, such as faecal energy loss and energy stored. It
should be noted that the BPD infants had very different
oxygen requirements, but that this patient group was
Fig. 1 Respiratory frequency and total daily energy expenditure.
Panel A: BPD infants (r2 = 0.82, P < 0.001). Panel B: Control infants
(r2 = 0.31, P = 0.46).
302
very homogeneous with respect to gender, gestational
age, post-conceptual age, and postnatal age. In the BPD
group, the frequency of respiration alone explained 82%
of the variance in Ee. In the four BPD patients with
elevated RR total daily energy expenditure was 25%
increased over control values. In contrast, infants with
BPD who demonstrated no tachypnoea had a normal Ee
(Fig. 1). Physical activity was not associated with Ee,
which is in agreement with previous results reported by
Yeh and co-workers [21]. Our results support the hy-
pothesis of Kurzner et al. [12] that an increase in me-
chanical work of breathing (and associated phenomena
such as sympatic activity) results in extra energy ex-
penditure in BPD infants. Kurzner et al. [12] found
significantly lower lung compliance and higher RR and
minute ventilation in BPD infants with growth retar-
dation in comparison with BPD infants without growth
failure (no control group of infants without pulmonary
disease was studied). Reduced lung compliance may
cause increased work of the breathing muscles in BPD
infants. Inefficient gas exchange and increased dead
space at the level of the alveoli may result in an increased
minute ventilation. Increases in ventilation (and RR)
and energy cost per breath could result in a dispropor-
tional increase of mechanical work of breathing in BPD
infants. Furthermore, excessive work of breathing, in-
creased Ee, and elevated RR could be associated, and
mutually enhancing, phenomena. However, from the
present study no inferences on causality can be made
and other explanations for the higher Ee in infants with
BPD, such as increased mechanical work by the heart or
hormonal disturbances, cannot be excluded.
The association between RR and Ee observed in our
study could be of value for the nutritional care of BPD
patients of comparable post-conceptual and postnatal
age. For practical purposes, the regression equation in
the patient group could be simplified to estimate the
extra energy required over the baseline in controls.
Taking into account 5% faecal energy loss, it can be
estimated from the regression coefficient that for a RR
over 50 breaths/min, BPD infants require an additional
energy intake of 7.5 kcal/kg per day for every additional
10 breaths / min.
Given the concern about growth failure in BPD, it is
of interest that the BPD infants in our study were re-
ceiving as much energy and gained weight at the same
rate as the controls. However, skeletal growth velocity
was significantly reduced in BPD infants compared to
controls (1.9 vs 3.5 mm/m/day, P < 0.05). A similar
trend was seen for all three skeletal parameters. Accu-
rate measurements of skeletal growth velocity in young
infants are very difficult and our measurements could
have been affected by observer bias. Our results suggest
that a possible effect on skeletal growth retardation in
BPD infants is not mediated by disturbances in energy
and protein balance. Although no inferences on rela-
tions with other factors can be made from our study, it
should be noted that there is growing concern about the
possible detrimental effects of corticosteroids on protein
metabolism and skeletal growth retardation in these
patients with BPD [10, 23–25].
In conclusion, this doubly labelled water study further
substantiates the evidence from previous studies that
energy expenditure in patients with severe BPD is in-
creased. Present respiratory status, and in particular the
infant’s respiratory frequency, appears to be strongly
associated with total energy expenditure in BPD infants.
This finding could be of practical value for the nutritional
management of BPD infants with severe lung disease.
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